1 enrolling by invitation. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Enrolling by invitation 1 |
Follow cGvHD: new trials by email Literature Review of cGvHD trials Research Report on cGvHD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase II Study Evaluating the Efficacy and Safety of ABSK021 (Pimicotinib)) in the Treatment of cGvHD Chronic Graft Versus Host Disease (cGvHD) ABSK021 - cGvHD | Phase 2 | Enrolling by invitation | Abbisko Therapeutics Co, Ltd | 64 | 2023-05-30 | 2024-08-12 |
Abbisko Therapeutics Co, Ltd (1)
China (1)